Cancer patients often lose excessive amounts of weight. This affects up to 80% of patients and is mainly due to a decrease in muscle mass and fatty tissue. This cancer-induced cachexia (CIC) is ...

Across disciplines, therapeutic areas and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition ...

CLARKSVILLE, Tenn. (WKRN) — Opening arguments began Tuesday in the case of Cheyenne Maddox following the 2022 death of her son, 13-year-old Kadaris Maddox. The prosecution stated Kadaris weighed 47 ...

Background: The Asian Working Group for Cachexia (AWGC) has released consensus criteria for diagnosing cachexia in Asians. Nevertheless, there is limited data regarding the application of these ...

Ponsegromab treatment led to sustained weight gain and GDF-15 suppression over 64 weeks in cancer-associated cachexia patients. Patients initially on placebo gained weight after switching to ...

MINNEAPOLIS, MN—Neutralizing growth differentiation factor 15 (GDF-15), a stress-activated cytokine, appears harmful to patients with heart failure (HF). That’s the bottom-line message from the phase ...

Recently, representing PanCAN Patient Services as our manager of research and education communication, I joined a group of patient advocates and researchers in Cambridge, UK, for an annual symposium ...

The Terasaki Institute for Biomedical Innovation announces a significant advancement in addressing the fight against cancer-associated cachexia (CAC), a life-threatening syndrome responsible for over ...

Los Angeles, CA – August 14, 2025 – The Terasaki Institute for Biomedical Innovation announces a significant advancement in addressing the fight against cancer-associated cachexia (CAC), a ...

Cachexia in older SCLC patients leads to inferior survival rates and increased treatment complications, such as dose reductions and incomplete chemotherapy courses. Patients with cachexia had ...